Ann ct« Biochem 1999: 36 likely to be perfect for every clinical situation. We would also like to suggest that continued availability of a range of methodologies (including competitive RIA), to enable investigation of the occasional clinically unexpected result, is highly desirable.
auspices of the International Society for Oncodevelopmental Biology and Medicine.
Hugh Mitchell felt that we had understated the limitations of sandwich assays when used for the measurement of hCG in oncology. We did, in fact, highlight the considerable variation in the extent to which different assays recognize different hCG-related molecules (reference 3, Table 7 ), and stated clearly that for clinical use in oncology a method measuring hCG and hCG/3 is desirable (reference 3, Table 10 ). However, we were unable to find any literature reports of patients in whom use of a two-site immunometric assay (IMA) failed to detect recurrence that was seen with a one-site radioimmunoassay (RIA).
Such discordant results, of course, are only noticed if they are actively looked for, e.g., by comparing results obtained by different methods for the same specimen, either in the same centre or in different centres. In a recent comparative study, hCG was measured for 55 patients by RIA and by two-site fluoroimmunometric assay (FIA).4 In the 24 patients with raised hCG, four discordant results were noted -in two cases hCG was raised when measured by RIA but not by FIA, and in two cases the reverse was true. The discordances observed were small, and did not affect diagnosis, but were sufficient to cause some temporary clinical concern about management. The authors concluded that no single assay is comprehensive in all clinical situations.
In a second and ongoing study being carried out through the UK National External Quality Assessment Scheme (NEQAS) for hCG, in collaboration with Hugh Mitchell, to determine the frequency of such discordance, undiluted serum samples from patients with early recurrence are being issued to a limited number of laboratories using different RIA and IMA methods. Initial results fail to establish a clear advantage for any type of methodology for the detection of hCG in the four cancer patient serum samples thus far investigated. (We would like to add in clarification that, in the UK NEQAS for hCG, specimens usually contain diluted sera from testicular cancer patients or pregnant women; they do not contain pregnancy urine.)
Only if and when results of objective studies demonstrate that discordant results obtained with two-site IMAs prejudice patient care would we feel able to proscribe the use of any particular method type. Until then, we agree with the view of Summers et al. 4 that no single hCG assay is
Influence of the laboratory upon requests for oral glucose tolerance tests for the diagnosis of diabetes mellitus
To test the hypothesis that previous recent blood glucose results may enable the diagnosis of diabetes mellitus to be established without the need to perform an oral glucose tolerance test (OGTI), we conducted a retrospective analysis of all the OGTI results performed by the Chemical Pathology department over a 6-month period. We identified blood glucose results, performed in the preceding 18 months, on all patients who had received an OGTI. The laboratory then issued guidelines, prepared with a consultant diabetologist, which described the indications for an OGTT in the diagnosis of diabetes mellitus. These guidelines (based upon the World Health Organization (WHO) criteria'< were sent to general practices and hospital doctors. We then re-audited our OGTT results over a further 6-month period. Statistical comparison was performed by the chi-squared test and significance was taken as P<0·05.
Eighty OGTTs were performed in the initial 6-month period. Six (7'5%) tests had to be aborted, five because the fasting blood glucose was greater than 11·1 mrnol/L and thus was diagnostic of diabetes mellitus, and one because the patient felt nauseous and faint after taking the glucose load. Thirty-nine patients (49-4%) were diagnosed as being non-diabetic, nine (11'4%) had impaired glucose tolerance and 31 (39'2%) had diabetic OGTT results. Sixty-nine (86'3%) of the patients had a blood glucose determination performed in the 18 months prior to the OGTT; of these, 12 had a random venous plasma glucose that exceeded 11·1 mmol/L, When the OGTT results of these 12 were analysed eight showed a result consistent with diabetes mellitus, two showed an impaired OGTT result and two were OGTTs performed during pregnancy and were shown to be nondiabetic according to the WHO criteria. Furthermore, 23 patients had a previous venous plasma glucose of less than 5·5 mrnol/L, which made the diagnosis of diabetes mellitus unlikely based upon the WHO criteria. Of these 23 patients (28,8% of the total group) 22 had nondiabetic OGTT results and one showed impaired glucose tolerance.
In the re-audit, 72 patients had an OGTT in the 6-month period after the guidelines were sent out. Fifty-eight patients (80'6%) were diagnosed as being non-diabetic, six (8'3%) had impaired glucose tolerance and eight (11'1 %) had diabetic OGTT results. Forty-one of the patients (56'9%) had had a blood glucose determination performed in the 18 months before the OGTT; of these only two had a random venous plasma glucose that exceeded 11·1 mmol/L, This was notably lower than the results obtained before the guidelines were issued. However, 21 patients (29'2%) had a previous venous plasma glucose of < 5·5 rnmol/L, which made the diagnosis of diabetes mellitus unlikely based upon the WHO criteria, and all had non-diabetic OGTT results. We conclude from this short audit that indications for performing an OGTT are frequently misunderstood by doctors but that laboratory guidelines may improve this. The problems associated with the OGTT have been discussed before.v' In 44% of the patients in our initial study the diagnosis of diabetes mellitus could probably have been made or excluded without resort to an OGTT. To complicate matters further, the American Diabetes Association has recently revised criteria for the diagnosis of diabetes mellitus.t
